Fawzy Nehmedo G, Panda Siva S, Fayad Walid, Shalaby ElSayed M, Srour Aladdin M, Girgis Adel S
Department of Pesticide Chemistry, National Research Centre Dokki Giza 12622 Egypt
Department of Chemistry & Physics, Augusta University Augusta GA 30912 USA.
RSC Adv. 2019 Oct 21;9(58):33761-33774. doi: 10.1039/c9ra05661k. eCollection 2019 Oct 18.
3,5-Bis(arylidene)--substituted-4-oxo-piperidine-1-carboxamides 24-51 were synthesized as curcumin mimics in a facile pathway through reaction of 3,5-bis(arylidene)-4-piperidones with the appropriate isocyanate in the presence of triethylamine. The 3,5'-stereochemical configuration was conclusively supported by single crystal X-ray studies of compounds 25 and 34. Most of the synthesized piperidinecarboxamides showed high anti-proliferative properties with potency higher than that of 5-fluorouracil (clinically approved drug against colon, breast and skin cancers) through MTT bio-assay. Some of them revealed anti-proliferative properties at sub-micromolar values (IC = 0.56-0.70 μM for compounds 29, 30 and 34-38 against HCT116; and IC = 0.64 μM for compound 30 against A431 cell lines) with promising inhibitory properties against human DNA topoisomerase IIα. The safe profile of the anti-proliferative active agents against the RPE1 normal cell line may prove their selectivity towards carcinoma cells. Robust molecular models (2D-QSAR, 3D-pharmacophore) supported the SAR and validated the observed bio-properties.
通过3,5-双(亚芳基)-4-哌啶酮与适当的异氰酸酯在三乙胺存在下反应,以简便的途径合成了3,5-双(亚芳基)-γ-取代-4-氧代哌啶-1-甲酰胺24 - 51作为姜黄素模拟物。化合物25和34的单晶X射线研究最终确定了3,5'-立体化学构型。通过MTT生物测定,大多数合成的哌啶甲酰胺显示出高抗增殖特性,其效力高于5-氟尿嘧啶(临床批准的抗结肠癌、乳腺癌和皮肤癌药物)。其中一些在亚微摩尔值下显示出抗增殖特性(化合物29、30和34 - 38对HCT116的IC = 0.56 - 0.70μM;化合物30对A431细胞系的IC = 0.64μM),对人DNA拓扑异构酶IIα具有有前景的抑制特性。抗增殖活性剂对RPE1正常细胞系的安全概况可能证明它们对癌细胞的选择性。强大的分子模型(二维定量构效关系、三维药效团)支持了构效关系并验证了观察到的生物学特性。